S. Galderisi et al., INFLUENCE OF MOCLOBEMIDE ON COGNITIVE FUNCTIONS OF 9 DEPRESSED-PATIENTS - PILOT TRIAL WITH NEUROPHYSIOLOGICAL AND NEUROPSYCHOLOGICAL INDEXES, Neuropsychobiology, 33(1), 1996, pp. 48-54
Quantitative electroencephalogram (QEEG) changes induced by the acute
administration of moclobemide (200 mg) in patients with major depressi
on include a transient increase in theta-activity, a slight augmentati
on of alpha-activity and a sustained increase in beta-activity. This Q
EEG profile distinguishes moclobemide from sedative antidepressants. A
42-day treatment with 400 mg/day of the drug produces a significant d
ecrease in the late positive-complex peak latency of the event-related
potentials, suggesting a positive effect on attention and cognitive f
unctions.